| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/19/2013 | CA2480319C Chimeric delta endotoxin protein of cry1ea and cry1ca |
| 02/19/2013 | CA2467434C Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 02/14/2013 | WO2013022808A2 Immunogenic protein conjugates and methods for making and using the same |
| 02/14/2013 | WO2013022320A2 Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof |
| 02/14/2013 | WO2013022051A1 Porous structure and method for producing same |
| 02/14/2013 | WO2013020266A1 Anti-mouse stk40 polyclonal antibody and preparation thereof |
| 02/14/2013 | US20130040900 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2013 | US20130040896 Methods and compositions for modulating angiogenesis and pericyte composition |
| 02/14/2013 | US20130040889 Factor VIII Fusion Protein |
| 02/14/2013 | US20130040888 Factor VIII Molecules With Reduced VWF Binding |
| 02/14/2013 | US20130040361 Novel antigen associated with the neovasculature of tumour metastases |
| 02/14/2013 | US20130040310 Ulk1 compositions, inhibitors, screening and methods of use |
| 02/14/2013 | US20130040309 Methods and Compositions for In-Vivo Enzyme Capture |
| 02/14/2013 | US20130039942 Compositions and Methods for Self-Adjuvanting Vaccines against Microbes and Tumors |
| 02/14/2013 | US20130039936 Immunogenic pote peptides and methods of use |
| 02/14/2013 | US20130039912 Robo1-fc fusion protein and use thereof for treating tumours |
| 02/14/2013 | US20130039911 Compositions and Methods for Targeted Immunomodulatory Antibodies and Fusion Proteins |
| 02/13/2013 | CN102925470A Method for recombining, expressing and producing human thymosin in yeast |
| 02/13/2013 | CN102924607A OGP-AcAP5 fusion protein for treating osteoporosis and thrombosis and nucleic acid for coding same |
| 02/13/2013 | CN102924606A Antitumor and thrombolytic double-effect chimeric protein of targeting tumor cell, preparation method and application thereof |
| 02/13/2013 | CN102924605A TELKP and LKP fusion immunotoxin and prokaryotic expression vector and preparation thereof |
| 02/13/2013 | CN102924604A Recombined vessel endothelium growth factor receptor, encoding genes thereof and application |
| 02/13/2013 | CN102924603A Fusion protein of human interferon and targeting peptide, and preparation thereof |
| 02/13/2013 | CN102924602A Gold ion adsorption protein and method for enriching and recovering gold ion |
| 02/13/2013 | CN102924585A Neublastin variants |
| 02/13/2013 | CN102924571A Rabies virus glycoprotein and nucleoprotein antigen epitope polypeptides, and screening and identification method and application thereof |
| 02/13/2013 | CN102206285B Chimeric peptide based on endomorphins 2 and neuropeptides FF, and synthesis and application thereof |
| 02/13/2013 | CN102028941B Neisseria meningitidis group B recombinant protein chimeric vaccine and preparation method thereof |
| 02/13/2013 | CN101993498B Adenovirus vector avian influenza recombinant vaccine |
| 02/13/2013 | CN101851294B Cell-penetrating peptide (Arg) 9 and lidamycin fusion protein (Arg) 9-LDP |
| 02/13/2013 | CN101693742B Anti-IGF-I receptor antibody |
| 02/12/2013 | US8372961 Polynucleotides encoding concatameric immunoadhesion molecules |
| 02/12/2013 | US8372404 Anti-C5/C5a antibodies and methods of use |
| 02/12/2013 | US8372388 Method for preparing a stable TNF-α vaccine |
| 02/07/2013 | WO2013019604A2 Protein production method |
| 02/07/2013 | WO2013018880A1 Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g |
| 02/07/2013 | WO2012169822A9 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same |
| 02/07/2013 | WO2012125652A3 Antibody and antibody mimetic for visualization and ablation of endogenous proteins |
| 02/07/2013 | US20130035472 Method of producing transcripts using cryptic splice sites |
| 02/07/2013 | US20130035471 Tetrameric Streptavidin Mutein With Reversible Biotin Binding Capability |
| 02/07/2013 | US20130035293 Compositions and methods for modulating dopamine neurotransmission |
| 02/07/2013 | US20130035287 Transient immortalization |
| 02/07/2013 | US20130035283 Engineered opsonin for pathogen detection and treatment |
| 02/07/2013 | US20130034561 Isolated mammalian monocyte cell genes; related reagents |
| 02/07/2013 | US20130034553 Fusion Polypeptides Capable of Activating Receptors |
| 02/07/2013 | US20130034552 Temperature sensitive conjugate compositions, and uses related thereto |
| 02/07/2013 | US20130034551 Wnt Antagonists and Methods of Treatment and Screening |
| 02/07/2013 | CA2842368A1 Switch costimulatory receptors |
| 02/06/2013 | EP2553102A2 High level expression of recombinant toxin proteins |
| 02/06/2013 | EP2553101A2 Protease activated cytokines |
| 02/06/2013 | EP2552967A2 Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same |
| 02/06/2013 | EP2552957A1 Antibodies with enhanced or suppressed effector function |
| 02/06/2013 | EP2552947A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 02/06/2013 | EP2552483A1 Antibody-based depletion of antigen-presenting cells and dendritic cells |
| 02/06/2013 | CN102178941B Novel helicobacter pylori multiepitope vaccine and preparation method thereof |
| 02/06/2013 | CN101870733B Poultry IL-2 and newcastle disease virus HN gene recombination fusion protein and application thereof |
| 02/06/2013 | CN101287487B Agents and methods based on the use of the EDA domain of fibronectin |
| 02/05/2013 | US8367803 Synthetic repetitive proteins, the production and use thereof |
| 02/05/2013 | US8367071 Stimulant of immunology response |
| 02/05/2013 | US8367067 Immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| 02/05/2013 | CA2512085C Protein complex, process for producing the same and use thereof |
| 02/05/2013 | CA2440221C Expression technology for proteins containing a hybrid isotype antibody moiety |
| 01/31/2013 | WO2013016693A2 Near-infrared light-activated proteins |
| 01/31/2013 | WO2013013639A1 Tnf-related apoptosis-inducing ligand fusion protein and preparation and use thereof |
| 01/31/2013 | WO2012122125A3 Compositions and methods targeting force generation in kinesin |
| 01/31/2013 | WO2012110878A3 Method of diagnosing cancer and diagnosis kit using measurement of nk cell activity |
| 01/31/2013 | WO2012078816A9 Proteins that efficiently generate singlet oxygen |
| 01/31/2013 | US20130030041 Near-infrared light-activated proteins |
| 01/31/2013 | US20130029911 Albumin fusion proteins |
| 01/31/2013 | US20130029908 Cerberus/coco derivatives and uses thereof |
| 01/31/2013 | US20130028930 Albumin Derivatives and Variants |
| 01/31/2013 | US20130028924 Constructs for enhancing immune responses |
| 01/31/2013 | US20130028919 Targeted pyrrolobenzodiazapine conjugates |
| 01/31/2013 | US20130028894 Methods of treating il-tif associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors |
| 01/31/2013 | CA2841541A1 Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene |
| 01/30/2013 | EP2551347A1 Pharmaceutical composition for preventing or treating cancer |
| 01/30/2013 | EP2550298A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors |
| 01/30/2013 | EP2550019A2 Temperature sensitive conjugate compositions, and uses related thereto |
| 01/30/2013 | CN102906266A Universal dengue virus sequences and methods of use |
| 01/30/2013 | CN102906120A Recombinant human G-CSF dimer and use thereof for treatment of neurological diseases |
| 01/30/2013 | CN102906119A Dual antagonist for TNF-A and Il-21 for preventing and treating autoimmune diseases |
| 01/30/2013 | CN102899342A Silurus asotus growth hormone (saGH)-cell penetrating peptide trans-activating transcriptional activator (TAT) fusion protein and its preparation method and use |
| 01/30/2013 | CN102898528A Calreticulin-soluble programmed death receptor 1 fusion protein, and preparation method and purpose thereof |
| 01/30/2013 | CN102898527A Pharmaceutical composition for preventing or treating cancer |
| 01/30/2013 | CN102898526A Tumor necrosis factor-related apoptosis-inducing ligand fusion protein, its preparation and application |
| 01/30/2013 | CN101914160B Composite of hepatitis B virus core antigen and heat shock protein and preparation method and application thereof |
| 01/29/2013 | US8362206 Chimeric proteins and uses thereof |
| 01/29/2013 | US8361729 Detection of cells expressing T1R2 taste receptor |
| 01/24/2013 | WO2013013105A2 Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage |
| 01/24/2013 | WO2013012674A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | WO2013011178A1 Rapid and accurate analysis of protein sialylation |
| 01/24/2013 | WO2013010225A1 Enzymes for degrading organophosphates |
| 01/24/2013 | WO2012142113A3 Isopeptide bond formation in bacillus species and uses thereof |
| 01/24/2013 | US20130025006 MODIFIED Cry1Ca INSECTICIAL Cry PROTEINS |
| 01/24/2013 | US20130023647 Modified human thymic stromal lymphopoietin |
| 01/24/2013 | US20130023643 Nuclear localization signal peptides derived from vp2 protein of chicken anemia virus and uses of said peptides |
| 01/24/2013 | US20130023464 Novel compounds and their effects on feeding behaviour |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022626 Long-acting human follicle-stimulating hormone formulation using immunoglobulin fragment |
| 01/24/2013 | US20130022614 IgE ANTIBODIES FOR THE TREATMENT OF CANCER |